adesso ventures

We are excited to announce our investment in Noah Labs, a digital health company at the forefront of remote patient monitoring. The €3M round was led by Nina Capital and supported by adesso ventures, DHZB Foundation and angel investors. Noah Labs is transforming remote patient monitoring for conditions like heart failure and hypertension. Their groundbreaking Noah Labs Vox platform leverages AI to analyze human voice, aiming to significantly improve patients' lives. We’re eager to collaborate with Oliver Piepenstock, Marcus Hott, and Dr. Leonhard Riehle on their mission to transform healthcare. Read more here: https://lnkd.in/dZDDTsiz

🎉 Exciting portfolio news 🎉 Our portfolio company acto just closed a €3.7M seed round, marking a significant milestone. As early backers since day one, we're immensely proud of their progress. Founded by Pascal Salmen and Andre Stollhans, acto addresses the pressing challenge of data management and decentralization for B2B teams.   468 Capital and Cusp Capital took the lead in this funding round, and we continued our support, driven by the team's track record of impressive achievements. acto will use the seed funding to further accelerate their technical advantage, i.e. augmenting customer data with data from the open web. This elevates the quality of acto's scoring model and insight prioritisation, helping B2B companies to interact with data even more effectively. Congratulations to Pascal, Andre, and the entire acto team on this achievement! Welcome to the adesso family: 468 Capital Cusp Capital another.vc Benedikt Franke Niklas Hellemann Find out more here: https://lnkd.in/eFEZA2rS

🎉 Great news from our portfolio! We are pleased to announce that Honic, the health data research platform, has successfully closed a financing round. With new lead investor Holland Capital, Honic will further expand the data infrastructure for medical research and play a key role in the emerging European Health Data Space (EHDS). The platform enables high-volume, cross-silo research and opens up new opportunities for medical developments in the European Union. Dr. Henrik Matthies, CEO, and Nora Sagel, Managing Director, of Honic, explain: "Over the past months, we have shown that the Honic platform can meet the expectations of the scientific community. With Holland Capital's investment, we are scaling up, always under the highest privacy and data security requirements." We congratulate Honic on this significant milestone and are proud to be part of this groundbreaking project! 🌐 #adessoVentures #HealthTech #Investment #Innovation #EuropeanHealthDataSpace Dieter von Holtzbrinck Ventures Isartal Ventures